Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Vaughn

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Biomarker Research|September 27, 2023
Survival of patients with transformed follicular lymphoma in the United States: a multiple cohort studyJohn L Vaughn, Narendranath Epperla
Cancers|March 14, 2026
JAK Inhibitors in the Treatment of T-Cell Lymphomas: Current Evidence and Future DirectionsGardenia Taza, Naveed Ahmed, John L Vaughn
Case Reports in Hematology|November 12, 2015
Acute Systolic Heart Failure Associated with Complement-Mediated Hemolytic Uremic SyndromeJohn L Vaughn, Jared M Moore, Spero R Cataland
Teaching and Learning in Medicine|July 10, 2015
Patients' Attitudes Toward Medical Student Participation Across Specialties: A Systematic ReviewJohn L Vaughn, Lanette R Rickborn, John A Davis
American Journal of Hematology|April 17, 2021
Racial disparities in the survival of patients with indolent non-Hodgkin lymphomas in the United StatesJohn L Vaughn, Daniela Spies, Ana C Xavier, et al.
Blood Cancer Journal|November 28, 2024
A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort studyJohn L Vaughn, Angela Ramdhanny, Malak Munir, et al.
Biomarker Research|April 24, 2025
Association of CAR-T approval on outcomes in patients with diffuse large B-cell lymphoma at the population level in the United StatesJohn L Vaughn, Angela Ramdhanny, Malak Munir, et al.
Hematological Oncology|January 9, 2026
Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort StudyJohn L Vaughn, Gardenia Taza, Malak Munir, et al.
Cancer Medicine|June 20, 2020
Recent survival trends in diffuse large B-cell lymphoma--Have we made any progress beyond rituximab?Narendranath Epperla, John L Vaughn, Megan Othus, et al.
Journal of Medical Case Reports|April 6, 2017
BRAF <sup>V600E</sup> expression in histiocytic sarcoma associated with splenic marginal zone lymphoma: a case reportJohn L Vaughn, C Eric Freitag, Jessica A Hemminger, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biomarker Research|September 27, 2023
Survival of patients with transformed follicular lymphoma in the United States: a multiple cohort studyJohn L Vaughn, Narendranath Epperla
Cancers|March 14, 2026
JAK Inhibitors in the Treatment of T-Cell Lymphomas: Current Evidence and Future DirectionsGardenia Taza, Naveed Ahmed, John L Vaughn
Case Reports in Hematology|November 12, 2015
Acute Systolic Heart Failure Associated with Complement-Mediated Hemolytic Uremic SyndromeJohn L Vaughn, Jared M Moore, Spero R Cataland
Teaching and Learning in Medicine|July 10, 2015
Patients' Attitudes Toward Medical Student Participation Across Specialties: A Systematic ReviewJohn L Vaughn, Lanette R Rickborn, John A Davis
American Journal of Hematology|April 17, 2021
Racial disparities in the survival of patients with indolent non-Hodgkin lymphomas in the United StatesJohn L Vaughn, Daniela Spies, Ana C Xavier, et al.
Blood Cancer Journal|November 28, 2024
A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort studyJohn L Vaughn, Angela Ramdhanny, Malak Munir, et al.
Biomarker Research|April 24, 2025
Association of CAR-T approval on outcomes in patients with diffuse large B-cell lymphoma at the population level in the United StatesJohn L Vaughn, Angela Ramdhanny, Malak Munir, et al.
Hematological Oncology|January 9, 2026
Trends in Incidence and Survival of Patients With Primary Effusion Lymphoma in the United States: A Population Based Cohort StudyJohn L Vaughn, Gardenia Taza, Malak Munir, et al.
Cancer Medicine|June 20, 2020
Recent survival trends in diffuse large B-cell lymphoma--Have we made any progress beyond rituximab?Narendranath Epperla, John L Vaughn, Megan Othus, et al.
Journal of Medical Case Reports|April 6, 2017
BRAF <sup>V600E</sup> expression in histiocytic sarcoma associated with splenic marginal zone lymphoma: a case reportJohn L Vaughn, C Eric Freitag, Jessica A Hemminger, et al.
Pageof 2